User profiles for Imran Satia

Dr. Imran Satia MA MB BChir (cantab) PhD MRCP

Assistant Professor, McMaster University
Verified email at mcmaster.ca
Cited by 2562

ERS guidelines on the diagnosis and treatment of chronic cough in adults and children

…, K Lai, L McGarvey, D Rigau, I Satia… - European …, 2020 - Eur Respiratory Soc
These guidelines incorporate the recent advances in chronic cough pathophysiology, diagnosis
and treatment. The concept of cough hypersensitivity has allowed an umbrella term that …

European Respiratory Society guidelines for the diagnosis of asthma in adults

R Louis, I Satia, I Ojanguren, F Schleich… - European …, 2022 - Eur Respiratory Soc
Although asthma is very common, affecting 5–10% of the population, the diagnosis of
asthma in adults remains a challenge in the real world, which results in both over- and under-…

Oxygen therapy for acutely ill medical patients: a clinical practice guideline

…, PD Farhoumand, JLK Siemieniuk, I Satia… - Bmj, 2018 - bmj.com
Applies to: Patients with acute stroke or myocardial infarction 1 00 99 98 97 96 95 94 93 92
91 90 89 88 87 Recommendation 1 Stop oxygen therapy no higher than 96% saturation …

Under-and over-diagnosis of COPD: a global perspective

T Ho, RP Cusack, N Chaudhary, I Satia, OP Kurmi - Breathe, 2019 - Eur Respiratory Soc
Globally, chronic obstructive pulmonary disease (COPD) is the fourth major cause of mortality
and morbidity and projected to rise to third within a decade as our efforts to prevent, identify…

[HTML][HTML] Aerosol delivery, but not intramuscular injection, of adenovirus-vectored tuberculosis vaccine induces respiratory-mucosal immunity in humans

…, M Kolb, MFC Medina, MB Dolovich, I Satia… - JCI insight, 2022 - ncbi.nlm.nih.gov
Background Adenovirus-vectored (Ad-vectored) vaccines are typically administered via im
injection to humans and are incapable of inducing respiratory mucosal immunity. However, …

XEN-D0501, a novel transient receptor potential vanilloid 1 antagonist, does not reduce cough in patients with refractory cough

…, MA Birrell, MA Wortley, SA Maher, I Satia… - American journal of …, 2017 - atsjournals.org
Rationale: Heightened cough responses to inhaled capsaicin, a transient receptor potential
vanilloid 1 (TRPV1) agonist, are characteristic of patients with chronic cough. However, …

A wearable tele-health system towards monitoring COVID-19 and chronic diseases

…, T Mondal, M Abolghasemian, I Satia… - IEEE Reviews in …, 2021 - ieeexplore.ieee.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a pandemic
since early 2020. The coronavirus disease 2019 (COVID-19) has already caused more than …

[HTML][HTML] Prevalence and contribution of respiratory viruses in the community to rates of emergency department visits and hospitalizations with respiratory tract …

I Satia, R Cusack, JM Greene, PM O'Byrne, KJ Killian… - PloS one, 2020 - journals.plos.org
Background The individual and combined contribution of viral prevalence in the community
to Emergency Department (ED) visits and hospitalizations with respiratory tract infections (…

[HTML][HTML] Capsaicin-evoked cough responses in asthmatic patients: evidence for airway neuronal dysfunction

I Satia, N Tsamandouras, K Holt, H Badri… - Journal of Allergy and …, 2017 - Elsevier
Background Cough in asthmatic patients is a common and troublesome symptom. It is
generally assumed coughing occurs as a consequence of bronchial hyperresponsiveness and …

The neurokinin-1 receptor antagonist orvepitant is a novel antitussive therapy for chronic refractory cough: results from a phase 2 pilot study (VOLCANO-1)

J Smith, D Allman, H Badri, R Miller, J Morris, I Satia… - Chest, 2020 - Elsevier
Background Substance P and the neurokinin-1 (NK-1) receptor are implicated in chronic
refractory cough pathophysiology. We assessed the efficacy and safety of orvepitant, a brain-…